Invivoscribe granted Novartis rights to jointly develop and commercialize a companion diagnostic test for Novartis' midostaurin for AML

Invivoscribe Technologies Inc.

U.S. / Medical Devices and Diagnostics

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Novartis AG

Switzerland / Large-Cap Biopharma (>=$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced